D86.83 Sarcoid iridocyclitis

Name of the Condition

• Common Name(s): Sarcoid iridocyclitis
• Medical Term: Sarcoid iridocyclitis

Summary

Sarcoid iridocyclitis is a form of ocular sarcoidosis characterized by inflammation of the iris and ciliary body. It is part of the broader systemic inflammatory disease sarcoidosis, which can affect multiple body systems. The condition involves granuloma formation in the eye, leading to symptoms such as eye pain, blurred vision, and photophobia. Diagnosis typically requires a combination of clinical evaluation, imaging, and sometimes biopsy.

Causes

The exact cause of sarcoid iridocyclitis is unknown. It is believed to result from an abnormal immune response to an environmental trigger, such as an infection, allergen, or toxin, in genetically susceptible individuals. The immune system overreacts, leading to chronic inflammation and granuloma formation in the iris and ciliary body.

Risk Factors

• Age: Most commonly diagnosed in individuals between 20 and 40 years old.
• Ethnicity: Higher prevalence in African-American and Northern European populations.
• Family History: A family history of sarcoidosis may increase risk.
• Gender: Slightly more common in females.

Symptoms

• Eye pain or discomfort.
• Blurred vision.
• Photophobia (sensitivity to light).
• Redness of the eye.
• Floaters or visual disturbances.
• Headaches.

Diagnosis

Diagnosis of sarcoid iridocyclitis involves a comprehensive eye examination, including slit-lamp biomicroscopy to assess inflammation. Additional tests may include optical coherence tomography (OCT) to evaluate retinal or macular involvement, fluorescein angiography to detect vascular changes, and systemic workup for sarcoidosis (e.g., chest imaging, blood tests). Biopsy of ocular tissue or other affected organs may be performed to confirm granuloma presence.

Treatment Options

Treatment focuses on reducing inflammation and managing symptoms. Corticosteroid eye drops are commonly used to control ocular inflammation. In severe cases, oral corticosteroids or immunosuppressive agents may be prescribed. Regular monitoring is essential to prevent complications like glaucoma or cataracts.

Prognosis and Follow-Up

With appropriate treatment, many patients experience improvement in symptoms and reduced inflammation. However, chronic or recurrent inflammation may lead to long-term complications. Follow-up care typically includes regular eye examinations to monitor for disease progression or treatment side effects.

Complications

• Glaucoma due to increased intraocular pressure.
• Cataracts from chronic inflammation or steroid use.
• Retinal damage or vision loss if untreated.
• Synechiae (adhesions) between the iris and lens.

Lifestyle & Prevention

• Protect eyes from bright light with sunglasses.
• Maintain overall health to support immune function.
• Avoid smoking, as it may worsen sarcoidosis symptoms.
• Follow up with healthcare providers for systemic sarcoidosis management.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision loss, severe eye pain, or worsening symptoms. Regular eye exams are recommended for individuals with sarcoidosis to detect ocular involvement early.

Tips for Medical Coders

When coding for sarcoid iridocyclitis (ICD10CM code D86.83), ensure documentation supports the diagnosis, including clinical findings, diagnostic tests, and treatment. Note the specificity of the code for ocular sarcoidosis involving the iris and ciliary body, and avoid using broader sarcoidosis codes unless the documentation confirms generalized disease. Verify that the code aligns with the patient’s clinical presentation and any associated systemic sarcoidosis documentation.